No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
None.
None.
No insider has filed a notice of proposed sale (Form 144) for LianBio in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FI
FNY Investment Advisers, LLC
|
14.0K | 0.01% | Unchanged | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding14.7K (Q1'25)
Change over 8 quarters+200
Share of the company0.010%
|
||||||
| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
TR
T. Rowe Price Health Sciences Fund, Inc.
|
$3.03M | 2.0M | 1.88% | 0.02% | September 30, 2023 |
|
BH
BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust
|
$2.75M | 615.2K | 0.57% | 0.14% | December 31, 2023 |
9 more funds behind a free account
See every fund holding LianBio and how much of the fund the position is.
Sign up freeLoading...